scholarly journals Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence

2019 ◽  
Vol 21 (6) ◽  
pp. 1349-1356 ◽  
Author(s):  
Pedro Mezquita Raya ◽  
Francisco Javier Ampudia Blasco ◽  
Barnaby Hunt ◽  
Virginia Martin ◽  
Brian Larsen Thorsted ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Real World ◽  
Clinical Evidence ◽  
Fixed Ratio ◽  
Insulin Degludec

scholarly journals Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective

2020 ◽  
Vol 23 (11) ◽  
pp. 1311-1320
Author(s):  
Johan Jendle ◽  
Åsa Ericsson ◽  
Bertil Ekman ◽  
Stefan Sjöberg ◽  
Jens Gundgaard ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Real World ◽  
Insulin Degludec

scholarly journals Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-Naïve People With Type-2 Diabetes

2013 ◽  
Vol 16 (3) ◽  
pp. A164
Author(s):  
P.D. Home ◽  
G.G. Gálvez ◽  
R. Malek ◽  
E. Hammerby ◽  
A. Nikolajsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Insulin Detemir ◽  
Short And Long Term

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand

2016 ◽  
Vol 14 (3) ◽  
pp. 281-292 ◽  
Author(s):  
Unchalee Permsuwan ◽  
Nathorn Chaiyakunapruk ◽  
Piyameth Dilokthornsakul ◽  
Kednapa Thavorn ◽  
Surasak Saokaew
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Insulin Glargine ◽  
Neutral Protamine Hagedorn
Sign in / Sign up

Export Citation Format

Share Document